Business
InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference
InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference Canada News...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, May 7, 2020\n\n\n\nVANCOUVER, May 7, 2020 /CNW/ - InMed Pharmaceuticals Inc. (\"InMed\" or the \"Company\") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), announced that Eric. A. Adams, President & CEO of InMed, will present a corporate overview as part of the upcoming virtual conference:\nCanaccord Genuity's 4th Annual Cannabis Conference on Tuesday, May 12th, 2020 at 12:00 PM PST / 3:00 PM EST.A webcast of the presentation will be available at: http://wsw.com/webcast/canaccord39/imlff as well as from the Investor page of the InMed website at https://investors.inmedpharma.com/.  \nAbout InMed: InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit www.inmedpharma.com.\nCautionary Note Regarding Forward-Looking Information:This news release contains \"forward-looking information\" and \"forward-looking statements\" (collectively, \"forward-looking information\") within the meaning of applicable securities laws. Forward-looking information is based on management's current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking information in this news release includes statements about: presenting at the Canaccord Genuity's 4th Annual Cannabis Conference on May 12th, 2020; leading the way in the clinical development of cannabinol (CBN); developing a pipeline of cannabinoid-based...